New research led by the University of Oxford has concluded that the antiparasitic drug ivermectin does not provide clinically meaningful benefits for treating COVID-19 in a largely vaccinated population.
A study led by NDPCHS Senior Qualitative Researcher Dr Aleksandra Borek reached number five on the BJGP Open\u2019s top 10 most read articles of 2023 list.
New research published in Nature Communications suggests that the currently recommended five-day course of molnupiravir, an antiviral treatment, may not be long enough to treat COVID-19.
On Tuesday 20 February, NDPCHS held our first Research Showcase. The valuable day brought together staff and students from across the department to share and discuss new research findings, seek collaboration for projects, and propose innovative \u2018dangerous ideas\u2019.
A new study from researchers in our department provides reassuring evidence that COVID-19 vaccines are safe and effective for people with blood cancers, despite their vulnerable immune systems.
Two articles, led or co-authored by Oxford researchers in the Nuffield Department of Primary Care Health Sciences, made the top 10 list of most read research articles in the BJGP for 2023.
A new study from the Nuffield Department of Primary Care Health Sciences, University of Oxford, and the University of Bristol, shows that an adapted version of an established domestic violence training and support programme can significantly improve GPs\u2019 ability to identify and assist patients experiencing domestic violence and abuse.
A new evaluation from the University of Oxford\u2019s ongoing PANORAMIC trial suggests that an antiviral treatment, called molnupiravir, used to treat COVID-19 may not be cost-effective at its current price of \u00a3513 per course, compared to usual NHS care and support, in the first six months after infection. However, it may be beneficial for patients over the age of 75.
A new University of Oxford-led study in UK general practice shows that staff need more and different training to equip them for delivering remote healthcare.
While most remote GP consultations are safe, the 'Remote by Default' study finds that GP consultations conducted remotely carry more risk for patients with some urgent conditions.
The training initiative builds the foundations to explore further collaborations encompassing joint research efforts, leadership programmes, and a shared commitment to advancing clinical trials.
The NHS is to expand the use of the OpenSAFELY research platform, behind the roll-out of new Covid-19 treatments, to help drive life-saving advances for other major diseases.
Discover how effective doctor-patient communication significantly boosts weight loss success in this new study. Simple, compassionate dialogue leads to better obesity care outcomes.
The University of Oxford\u2019s Nuffield Department of Primary Care Health Sciences, in partnership with RAND Europe, is excited to launch the DECIDE (Digitally Enabled Care in Diverse Environments) initiative, to help transform healthcare through rapid evaluation of technology-enabled remote monitoring.
Researchers from the Nuffield Department of Primary Care Health Sciences, University of Oxford BISQIT (Behaviour, Implementation Science and Qualitative methods in Infections) team engaged the public about behaviours to promote preventing common infections and less unnecessary antibiotic use as part of the Oxford Science + Ideas Festival.
The researchers from the University of Oxford's Nuffield Department of Primary Care Health Sciences and Oxford University Hospitals (OUH) NHS Foundation Trust interviewed primary care practitioners about their experiences of supporting women's healthcare needs.
![\"\"](\"https://www.phc.ox.ac.uk/news/new-study-shows-ivermectin-lacks-meaningful-benefits-in-covid-19-treatment/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n